Natus Medical (BABY) Tops Q2 EPS by 3c; Raises Outlook

Natus Medical (NASDAQ: BABY) reported Q2 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $96 million versus the consensus estimate of $92.71 million.

"I am very pleased with our record second quarter revenues and earnings per share. Our domestic neurodiagnostic and newborn care businesses reported record results in the second quarter. Our fast growing new service initiatives continued their strong performance as NicView revenues grew by 90 percent, Peloton by 80 percent and GND by 45 percent verse our second quarter last year. We remain committed to achieving our full year 2016 non-GAAP operating margin goal of 20%," said Jim Hawkins, President and Chief Executive Officer of the Company.

"We recently announced the acquisition of RetCam, the worldwide leader in imaging systems used to diagnose and monitor a range of ophthalmic maladies in premature infants. We believe RetCam technology has exciting growth opportunities in the years ahead and are looking forward to further developing the newborn retinal imaging and screening market. Our growth strategy continues to include selective acquisitions like RetCam and potentially larger acquisitions that will expand our product offerings in the markets we serve," said Hawkins.

GUIDANCE:

Natus Medical sees Q3 2016 EPS of $0.41-$0.43, versus the consensus of $0.44. Natus Medical sees Q3 2016 revenue of $97-98 million, versus the consensus of $100.24 million.

Natus Medical sees FY2016 EPS of $1.67-$1.70, versus prior guidance of $1.61-$1.65 and the consensus of $1.66. Natus Medical sees FY2016 revenue of $388-390 million, versus prior guidance of $378-382 million and the consensus of $386.99 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
• INVO Fertility (IVF) Tops Q2 EPS by 105c